blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3390646

EP3390646 - A NOVEL PROCESS FOR PRODUCTION OF PURIFIED RECOMBINANT CHOLERA TOXIN B (rCTB) AND FORMU LATION THEREON [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  16.10.2020
Database last updated on 28.09.2024
FormerRequest for examination was made
Status updated on  21.09.2018
FormerThe international publication has been made
Status updated on  23.06.2017
Most recent event   Tooltip16.10.2020Application deemed to be withdrawnpublished on 18.11.2020  [2020/47]
Applicant(s)For all designated states
Msd Wellcome Trust Hilleman Laboratories Pvt. Ltd.
D-15 Ground Floor
Jangpura Extension
New Delhi 110014 / IN
[2018/43]
Inventor(s)01 / SHARMA, Tarun
WZ-37 Second Floor Hari Singh Park
New Multan Nagar New Delhi 110056 / IN
02 / JOSHI, Neeraj
A1/93 Gali No. 3
Rajapuri
Uttam Nagar New Delhi 110059 / IN
03 / KANCHAN, Vibhu
Pocket D Flat No. 211 Ground Floor
Sarita Vihar New Delhi 110076 / IN
04 / SIKRIWAL, Deepa
Pocket D Flat no. 211 Ground Floor
Sarita Vihar
New Delhi New Delhi 110076 / IN
05 / SHUKLA, Nidhi
A062 G. C Grand Apartments
Vaibhav Khand
Indirapuram
Ghaziabad
Uttar Pradesh Ghaziabad 201014 / IN
06 / GILL, Dr. Davinder
E-9/16 Ground Floor
Vasant Vihar
New Delhi New Delhi 110057 / IN
 [2018/43]
Representative(s)Novitas Patent AB
P.O. Box 55557
102 04 Stockholm / SE
[2018/43]
Application number, filing date16874999.209.12.2016
[2018/43]
WO2016IB57460
Priority number, dateIN2015DEL408914.12.2015         Original published format: IN 4089DE2015
[2018/43]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017103748
Date:22.06.2017
Language:EN
[2017/25]
Type: A1 Application with search report 
No.:EP3390646
Date:24.10.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 22.06.2017 takes the place of the publication of the European patent application.
[2018/43]
Search report(s)International search report - published on:IN22.06.2017
(Supplementary) European search report - dispatched on:EP30.09.2019
ClassificationIPC:C12P1/04, C07K14/28, A61P31/04
[2019/25]
CPC:
A61K39/107 (EP,KR,US); C07K14/28 (EP,KR,US); A61P31/04 (EP,US);
C12P1/04 (US); C12P21/02 (EP,KR,US); A61K2039/521 (EP,KR,US);
C12N1/20 (US); C12N15/86 (US); Y02A50/30 (EP) (-)
Former IPC [2018/43]C12P1/04, C07K14/28
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/43]
TitleGerman:NEUARTIGES VERFAHREN ZUR HERSTELLUNG VON GEREINIGTEM REKOMBINANTEM CHOLERATOXIN B (RCTB) UND FORMULIERUNG DARAUS[2018/43]
English:A NOVEL PROCESS FOR PRODUCTION OF PURIFIED RECOMBINANT CHOLERA TOXIN B (rCTB) AND FORMU LATION THEREON[2018/43]
French:NOUVEAU PROCÉDÉ DE PRODUCTION DE TOXINE B DE CHOLÉRA, RECOMBINANTE, PURIFIÉE (TBCR) ET FORMULATION CORRESPONDANTE[2018/43]
Entry into regional phase07.05.2018National basic fee paid 
07.05.2018Search fee paid 
07.05.2018Designation fee(s) paid 
07.05.2018Examination fee paid 
Examination procedure07.05.2018Examination requested  [2018/43]
07.05.2018Date on which the examining division has become responsible
03.06.2020Application deemed to be withdrawn, date of legal effect  [2020/47]
24.06.2020Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2020/47]
Fees paidRenewal fee
29.11.2018Renewal fee patent year 03
09.12.2019Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]RU2456996  (FEDERAL NOE G UCHREZHDENIE ZDRAVOOKHRANENIJA ROSSIJSKIJ NI PROTIVOCHUMNYJ INST MIKROB FEDERAL NOJ SL [RU]) [A] 1-11;
 [A]  - C Bergquist ET AL, "Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina", Infection and Immunity, United States, (19970701), pages 2676 - 2684, URL: https://iai.asm.org/content/iai/65/7/2676.full.pdf, XP055585512 [A] 1-6
 [Y]  - SANCHEZ J ET AL, "RECOMBINANT SYSTEM FOR OVEREXPRESSION OF CHOLERA TOXIN B SUBUNIT IN VIBRIO CHOLERAE AS A BASIS FOR VACCINE DEVELOPMENT", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, NATIONAL ACADEMY OF SCIENCES, US, (19890101), vol. 86, doi:10.1073/PNAS.86.2.481, ISSN 0027-8424, pages 481 - 485, XP009042243 [Y] 1-5,7-11 * page 482, column left *

DOI:   http://dx.doi.org/10.1073/pnas.86.2.481
 [Y]  - KRYSTAL TEASLEY HAMORSKY ET AL, "Rapid and Scalable Plant-based Production of a Cholera Toxin B Subunit Variant to Aid in Mass Vaccination against Cholera Outbreaks", PLOS NEGLECTED TROPICAL DISEASES, (20130307), vol. 7, no. 3, doi:10.1371/journal.pntd.0002046, page e2046, XP055535643 [Y] 1-5,7-11 * page 3, column right *

DOI:   http://dx.doi.org/10.1371/journal.pntd.0002046
 [A]  - JOHN CLEMENS ET AL, "New-generation vaccines against cholera", NATURE REVIEWS / GASTROENTEROLOGY & HEPATOLOGY, US, (20111108), vol. 8, no. 12, doi:10.1038/nrgastro.2011.174, ISSN 1759-5045, pages 701 - 710, XP055585502 [A] 1-11

DOI:   http://dx.doi.org/10.1038/nrgastro.2011.174
 [Y]  - Holmgren, "Single-strain improved oral cholera vaccine", (20150101), URL: https://www.msb.se/RibData/Filer/pdf/27943.pdf, (20190503), XP055585428 [Y] 1-5,7-11 * page 10 *
 [Y]  - M. BOUSTANSHENAS ET AL, "Investigation into immunological responses against a native recombinant CTB whole-cell Vibrio cholerae vaccine in a rabbit model", JOURNAL OF APPLIED MICROBIOLOGY., GB, (20130201), vol. 114, no. 2, doi:10.1111/jam.12043, ISSN 1364-5072, pages 509 - 515, XP055392332 [Y] 1-5,7-11 * table 2 *

DOI:   http://dx.doi.org/10.1111/jam.12043
International search[Y]  - "Single-strain improved oral cholera vaccine", Scientific report- Jan Holmgren, Sara Brunnberg, (20150900), XP055549131 [Y] 1-11 * . *refer page 10, paragraph 3; page 10, paragraph 1; page 12, paragrapgh 1 lines 9-12*
 [Y]  - M. BOUSTANSHENAS et al., "Investigation into immunological responses against a native recombinant CTB whole- cell Vibrio cholerae vaccine in a rabbit model", Journal of Applied Microbiology, (20130200), vol. 114, no. 2, pages 509 - 515, XP 055392332 [Y] 1-11 *refer material and method, Abstract*
 [Y]  - P. SLOS et al., "Recombinant Cholera Toxin B-Subunit in Escherichia coli: High-Level Secretion, Purification, and Characterization", Protein Expression and Purification, (19941000), vol. 5, no. 5, pages 518 - 526, XP 024799899 [Y] 1-11 * . *refer whole document*
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.